Bessemer Group
WX

Bessemer Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bessemer Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-368
Closed -$16K – 1851
2015
Q3 		$16K Sell
368
-145
-28% -$6.12K ﹤0.01% 1143
2015
Q2 		$22K Buy
513
+271
+112% +$11.4K ﹤0.01% 1119
2015
Q1 		$9K Hold
242
– – ﹤0.01% 1250
2014
Q4 		$8K Buy
+242
New +$8.55K ﹤0.01% 1295

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Bessemer Group's WX Position: Q4 2015 in Review

Bessemer Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 368 shares — an estimated $16K sold.

Bessemer Group first reported a position in WX in Q4 2014 and held it in 4 quarters. The position peaked at $22K in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Bessemer Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Bessemer Group sold 368 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $16K.
  • Bessemer Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2014 and held it in 4 quarters.
  • Bessemer Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $22K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Bessemer Group's 13F filing for Q4 2015, filed 12 Feb 2016.